President & CEO
Kevin Lind has over 20 years of experience in the life sciences industry. He has served as Longboard Pharmaceuticals’ President and Chief Executive Officer since March 2020 and as a member of its board since the company’s inception in January 2020. Prior to joining Longboard Pharmaceuticals, Mr. Lind served as Executive Vice President and Chief Financial Officer of Arena Pharmaceuticals (acquired by Pfizer) from June 2016 to February 2020. Prior to Arena, Mr. Lind was a Principal focused on healthcare at TPG Special Situations Partners, a global investment firm, from January 2009 to June 2016. Mr. Lind was a member of the TPG Pharma Partners effort at TPG-Axon, a global investment firm, from 2006 to 2008. He served in various capacities as a healthcare investment banker at Lehman Brothers, Inc., a former global financial services firm, from 1998 to 2002 and 2004 to 2006. Mr. Lind received a B.S. from Stanford University in Biological Sciences and an MBA from UCLA Anderson School of Management.